The global pharmaceutical company GlaxoSmithKline plc (GSK) announced the strategic separation of its Consumer Healthcare business, to be completed by mid-2022. The New …
Sanofi’s CEO, Paul Hudson, said that the mRNA-based (messenger Ribonucleic acid) COVID-19 vaccine developed by the pharma giant and Translate Bio will not …
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease …
Agenus Inc (NASDAQ:AGEN), an immunology company discovering and developing innovative treatments for cancers and other diseases, announced that GlaxoSmithKline plc (ADR) (NYSE:GSK) received a …
